LCN2 and acute kidney injury: Assessment of the predictive value would require the measurement of KIM-1 and NGAL in large, prospective, observational cohort studies in children and adults receiving aminoglycoside therapy, using standardised AKI definitions13 and phenotypic criteria48, and powered for appropriate outcomes (AKI, renal replacement therapy, mortality).